#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13954	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2347	593.0	0	.	n	.	0	C451T	SNP	451	451	C	830	830	T	797	T	748	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13954	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2347	593.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1563	1563	C	837	C	774	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13954	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2347	593.0	0	HET	.	.	.	C207T	.	207	207	C	586	586	C	787	C,T	593,144	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26402	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3581	735.0	0	.	n	.	0	T695C	SNP	695	695	T	1060	1060	C	798	C,G	750,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26402	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3581	735.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2336	2336	C	795	C	737	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26402	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3581	735.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2410	2410	A	796	A	752	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26402	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3581	735.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2962	2962	C	837	C	791	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2028	folP	855	855	100.0	folP.l15.c4.ctg.1	1611	125.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1156	1158	AGC	191;191;193	A;G;C	181;182;180	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5984	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3497	170.5	1	SNP	p	S91F	1	.	.	271	273	TTC	650	652	TTC	213;215;216	T;T;C	203;202;203	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5984	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3497	170.5	1	SNP	p	G95N	0	.	.	283	285	GGC	662	664	GGC	224;223;223	G,T;G;C	210,1;208;208	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5984	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3497	170.5	1	SNP	p	D95G	1	.	.	283	285	GGC	662	664	GGC	224;223;223	G,T;G;C	210,1;208;208	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1678	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1455	115.1	1	SNP	p	G45D	0	.	.	133	135	GGC	554	556	GGC	191;193;195	G;G;C	184;182;183	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	848	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	983	85.7	0	.	n	.	0	A197.	DEL	197	197	A	558	558	A	199	A	193	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5566	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2951	187.8	1	SNP	p	D86N	0	.	.	256	258	GAC	490	492	GAC	198;198;200	G;A;C	185;184;188	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5566	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2951	187.8	1	SNP	p	R87I	0	.	.	259	261	CGT	493	495	CGT	198;202;202	C;G;T	188;191;190	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5566	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2951	187.8	1	SNP	p	S87R	1	.	.	259	261	CGT	493	495	CGT	198;202;202	C;G;T	188;191;190	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5566	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2951	187.8	1	SNP	p	R87W	0	.	.	259	261	CGT	493	495	CGT	198;202;202	C;G;T	188;191;190	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5566	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2951	187.8	1	SNP	p	S88P	0	.	.	262	264	TCC	496	498	TCC	201;200;197	T;C;C	188;188;182	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3962	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2498	157.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1492	1494	GGC	184;181;182	G;G;C	168;166;165	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1250	1252	GCC	201;201;200	G;C;C	187;189;186	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1253	1255	ATG	201;198;198	A;T;G	189;186;185	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1265	1267	ACC	190;192;194	A;C,T;C	179;179,1;180	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1265	1267	ACC	190;192;194	A;C,T;C	179;179,1;180	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1766	1768	ACC	195;194;196	A;C;C	172;180;184	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1820	1822	GCG	208;210;205	G;C;G	199;200;196	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1820	1822	GCG	208;210;205	G;C;G	199;200;196	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1943	1945	GGT	168;166;166	G;G;T	149;147;146	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1952	1954	AGC	162;162;161	A;G;C	145;145;146	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3950	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2292	171.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1970	1972	CCG	135;137;135	C,G;C;GCCC,GGGCCCC	109,7;109;103,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5804	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3228	179.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1693	1695	CCG	219;218;218	C,T;C;G,A	195,1;200;193,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2424	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1967	122.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	616	616	C	190	C	171	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	297	91.03	porB1a.l15.c30.ctg.1	1386	19.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1111	1113	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	297	91.03	porB1a.l15.c30.ctg.1	1386	19.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1114	1116	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	297	91.03	porB1a.l15.c30.ctg.1	1386	19.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1138	1140	GCA	10;11;11	G;C;A	10;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	297	91.03	porB1a.l15.c30.ctg.1	1386	19.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1161	1163	GTA	14;14;14	G;T;A	14;14;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	284	porB1a	984	297	91.03	porB1a.l15.c30.ctg.1	1386	19.3	0	.	p	.	0	S236fs	FSHIFT	706	706	A	1167	1167	A	13	A	13	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2888	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1542	186.1	0	.	p	.	0	S255N	NONSYN	763	765	AGC	1110	1112	AAC	233;232;236	A;A;C	220;220;224	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2888	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1542	186.1	1	SNP	p	G120K	1	.	.	358	360	AAG	705	707	AAG	254;252;248	A;A;G	240;239;231	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2888	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1542	186.1	1	SNP	p	N121D	0	.	.	361	363	AAC	708	710	AAC	251;248;247	A;A;C	237;236;233	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2888	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1542	186.1	1	SNP	p	A121N	1	.	.	361	363	AAC	708	710	AAC	251;248;247	A;A;C	237;236;233	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10230	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4852	210.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1134	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1079	104.5	1	SNP	p	V57M	1	.	.	169	171	ATG	522	524	ATG	253;253;250	A;T;G	239;239;237	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
